nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—CYP2C19—Tamoxifen—pancreatic cancer	0.0797	0.148	CbGbCtD
Timolol—ABCB1—Tamoxifen—pancreatic cancer	0.0643	0.119	CbGbCtD
Timolol—CYP2D6—Tamoxifen—pancreatic cancer	0.0606	0.112	CbGbCtD
Timolol—ABCB1—Gemcitabine—pancreatic cancer	0.0554	0.103	CbGbCtD
Timolol—ABCB1—Erlotinib—pancreatic cancer	0.0547	0.101	CbGbCtD
Timolol—CYP2D6—Erlotinib—pancreatic cancer	0.0515	0.0954	CbGbCtD
Timolol—ABCB1—Irinotecan—pancreatic cancer	0.0494	0.0914	CbGbCtD
Timolol—ABCB1—Docetaxel—pancreatic cancer	0.0362	0.067	CbGbCtD
Timolol—ABCB1—Sunitinib—pancreatic cancer	0.036	0.0667	CbGbCtD
Timolol—ABCB1—Doxorubicin—pancreatic cancer	0.027	0.0499	CbGbCtD
Timolol—CYP2D6—Doxorubicin—pancreatic cancer	0.0254	0.0471	CbGbCtD
Timolol—Diarrhoea—Sunitinib—pancreatic cancer	0.000329	0.000853	CcSEcCtD
Timolol—Dysgeusia—Docetaxel—pancreatic cancer	0.000329	0.000852	CcSEcCtD
Timolol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000328	0.000849	CcSEcCtD
Timolol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000327	0.000847	CcSEcCtD
Timolol—Asthma—Epirubicin—pancreatic cancer	0.000325	0.000842	CcSEcCtD
Timolol—Pain—Fluorouracil—pancreatic cancer	0.000325	0.000841	CcSEcCtD
Timolol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000324	0.00084	CcSEcCtD
Timolol—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000321	0.000833	CcSEcCtD
Timolol—Dizziness—Sunitinib—pancreatic cancer	0.000318	0.000825	CcSEcCtD
Timolol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000318	0.000825	CcSEcCtD
Timolol—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000318	0.000824	CcSEcCtD
Timolol—Angina pectoris—Epirubicin—pancreatic cancer	0.000317	0.000821	CcSEcCtD
Timolol—Breast disorder—Doxorubicin—pancreatic cancer	0.000315	0.000815	CcSEcCtD
Timolol—Abdominal pain—Irinotecan—pancreatic cancer	0.000314	0.000812	CcSEcCtD
Timolol—Body temperature increased—Irinotecan—pancreatic cancer	0.000314	0.000812	CcSEcCtD
Timolol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000313	0.000811	CcSEcCtD
Timolol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000311	0.000806	CcSEcCtD
Timolol—Vomiting—Sunitinib—pancreatic cancer	0.000306	0.000793	CcSEcCtD
Timolol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000305	0.000791	CcSEcCtD
Timolol—Dysuria—Epirubicin—pancreatic cancer	0.000304	0.000788	CcSEcCtD
Timolol—Rash—Sunitinib—pancreatic cancer	0.000304	0.000786	CcSEcCtD
Timolol—Dermatitis—Sunitinib—pancreatic cancer	0.000303	0.000786	CcSEcCtD
Timolol—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000302	0.000783	CcSEcCtD
Timolol—Urticaria—Fluorouracil—pancreatic cancer	0.000302	0.000782	CcSEcCtD
Timolol—Headache—Sunitinib—pancreatic cancer	0.000302	0.000781	CcSEcCtD
Timolol—Syncope—Docetaxel—pancreatic cancer	0.000301	0.00078	CcSEcCtD
Timolol—Asthma—Doxorubicin—pancreatic cancer	0.000301	0.000779	CcSEcCtD
Timolol—Body temperature increased—Fluorouracil—pancreatic cancer	0.0003	0.000778	CcSEcCtD
Timolol—Palpitations—Docetaxel—pancreatic cancer	0.000297	0.000769	CcSEcCtD
Timolol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000295	0.000765	CcSEcCtD
Timolol—Weight decreased—Epirubicin—pancreatic cancer	0.000294	0.000762	CcSEcCtD
Timolol—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000293	0.00076	CcSEcCtD
Timolol—Cough—Docetaxel—pancreatic cancer	0.000293	0.000759	CcSEcCtD
Timolol—Angina pectoris—Doxorubicin—pancreatic cancer	0.000293	0.000759	CcSEcCtD
Timolol—Hypersensitivity—Irinotecan—pancreatic cancer	0.000292	0.000757	CcSEcCtD
Timolol—Hypertension—Docetaxel—pancreatic cancer	0.00029	0.000751	CcSEcCtD
Timolol—Chest pain—Docetaxel—pancreatic cancer	0.000286	0.000741	CcSEcCtD
Timolol—Myalgia—Docetaxel—pancreatic cancer	0.000286	0.000741	CcSEcCtD
Timolol—Arthralgia—Docetaxel—pancreatic cancer	0.000286	0.000741	CcSEcCtD
Timolol—Nausea—Sunitinib—pancreatic cancer	0.000286	0.000741	CcSEcCtD
Timolol—Asthenia—Irinotecan—pancreatic cancer	0.000285	0.000737	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000284	0.000736	CcSEcCtD
Timolol—Conjunctivitis—Epirubicin—pancreatic cancer	0.000282	0.00073	CcSEcCtD
Timolol—Dysuria—Doxorubicin—pancreatic cancer	0.000281	0.000729	CcSEcCtD
Timolol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00028	0.000725	CcSEcCtD
Timolol—Dry mouth—Docetaxel—pancreatic cancer	0.00028	0.000725	CcSEcCtD
Timolol—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00028	0.000724	CcSEcCtD
Timolol—Sweating—Epirubicin—pancreatic cancer	0.000278	0.00072	CcSEcCtD
Timolol—Asthenia—Gemcitabine—pancreatic cancer	0.000277	0.000718	CcSEcCtD
Timolol—Confusional state—Docetaxel—pancreatic cancer	0.000276	0.000716	CcSEcCtD
Timolol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000274	0.00071	CcSEcCtD
Timolol—Oedema—Docetaxel—pancreatic cancer	0.000274	0.00071	CcSEcCtD
Timolol—Epistaxis—Epirubicin—pancreatic cancer	0.000273	0.000708	CcSEcCtD
Timolol—Pruritus—Gemcitabine—pancreatic cancer	0.000273	0.000708	CcSEcCtD
Timolol—Infection—Docetaxel—pancreatic cancer	0.000272	0.000706	CcSEcCtD
Timolol—Weight decreased—Doxorubicin—pancreatic cancer	0.000272	0.000705	CcSEcCtD
Timolol—Sinusitis—Epirubicin—pancreatic cancer	0.000272	0.000705	CcSEcCtD
Timolol—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000271	0.000703	CcSEcCtD
Timolol—Diarrhoea—Irinotecan—pancreatic cancer	0.000271	0.000703	CcSEcCtD
Timolol—Agranulocytosis—Epirubicin—pancreatic cancer	0.000271	0.000701	CcSEcCtD
Timolol—Shock—Docetaxel—pancreatic cancer	0.00027	0.000699	CcSEcCtD
Timolol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000269	0.000696	CcSEcCtD
Timolol—Pruritus—Fluorouracil—pancreatic cancer	0.000269	0.000696	CcSEcCtD
Timolol—Skin disorder—Docetaxel—pancreatic cancer	0.000266	0.00069	CcSEcCtD
Timolol—Bradycardia—Epirubicin—pancreatic cancer	0.000265	0.000686	CcSEcCtD
Timolol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000264	0.000685	CcSEcCtD
Timolol—Dizziness—Irinotecan—pancreatic cancer	0.000262	0.000679	CcSEcCtD
Timolol—Anorexia—Docetaxel—pancreatic cancer	0.000261	0.000677	CcSEcCtD
Timolol—Rhinitis—Epirubicin—pancreatic cancer	0.000261	0.000676	CcSEcCtD
Timolol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000261	0.000675	CcSEcCtD
Timolol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00026	0.000673	CcSEcCtD
Timolol—Sweating—Doxorubicin—pancreatic cancer	0.000257	0.000666	CcSEcCtD
Timolol—Oedema peripheral—Epirubicin—pancreatic cancer	0.000256	0.000664	CcSEcCtD
Timolol—Hypotension—Docetaxel—pancreatic cancer	0.000256	0.000664	CcSEcCtD
Timolol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000256	0.000663	CcSEcCtD
Timolol—Epistaxis—Doxorubicin—pancreatic cancer	0.000253	0.000655	CcSEcCtD
Timolol—Vomiting—Irinotecan—pancreatic cancer	0.000252	0.000653	CcSEcCtD
Timolol—Sinusitis—Doxorubicin—pancreatic cancer	0.000252	0.000652	CcSEcCtD
Timolol—Dizziness—Fluorouracil—pancreatic cancer	0.000251	0.000651	CcSEcCtD
Timolol—Visual impairment—Epirubicin—pancreatic cancer	0.000251	0.00065	CcSEcCtD
Timolol—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00025	0.000649	CcSEcCtD
Timolol—Rash—Irinotecan—pancreatic cancer	0.00025	0.000648	CcSEcCtD
Timolol—Dermatitis—Irinotecan—pancreatic cancer	0.00025	0.000647	CcSEcCtD
Timolol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00025	0.000647	CcSEcCtD
Timolol—Headache—Irinotecan—pancreatic cancer	0.000248	0.000644	CcSEcCtD
Timolol—Insomnia—Docetaxel—pancreatic cancer	0.000248	0.000642	CcSEcCtD
Timolol—Paraesthesia—Docetaxel—pancreatic cancer	0.000246	0.000638	CcSEcCtD
Timolol—Vomiting—Gemcitabine—pancreatic cancer	0.000246	0.000636	CcSEcCtD
Timolol—Bradycardia—Doxorubicin—pancreatic cancer	0.000245	0.000635	CcSEcCtD
Timolol—Dyspnoea—Docetaxel—pancreatic cancer	0.000244	0.000633	CcSEcCtD
Timolol—Somnolence—Docetaxel—pancreatic cancer	0.000244	0.000631	CcSEcCtD
Timolol—Rash—Gemcitabine—pancreatic cancer	0.000244	0.000631	CcSEcCtD
Timolol—Dermatitis—Gemcitabine—pancreatic cancer	0.000243	0.00063	CcSEcCtD
Timolol—Eye disorder—Epirubicin—pancreatic cancer	0.000243	0.00063	CcSEcCtD
Timolol—Tinnitus—Epirubicin—pancreatic cancer	0.000243	0.000629	CcSEcCtD
Timolol—Headache—Gemcitabine—pancreatic cancer	0.000242	0.000627	CcSEcCtD
Timolol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000242	0.000626	CcSEcCtD
Timolol—Vomiting—Fluorouracil—pancreatic cancer	0.000242	0.000626	CcSEcCtD
Timolol—Rhinitis—Doxorubicin—pancreatic cancer	0.000241	0.000625	CcSEcCtD
Timolol—Dyspepsia—Docetaxel—pancreatic cancer	0.000241	0.000625	CcSEcCtD
Timolol—Rash—Fluorouracil—pancreatic cancer	0.00024	0.00062	CcSEcCtD
Timolol—Dermatitis—Fluorouracil—pancreatic cancer	0.000239	0.00062	CcSEcCtD
Timolol—Decreased appetite—Docetaxel—pancreatic cancer	0.000238	0.000617	CcSEcCtD
Timolol—Headache—Fluorouracil—pancreatic cancer	0.000238	0.000616	CcSEcCtD
Timolol—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000237	0.000615	CcSEcCtD
Timolol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000237	0.000613	CcSEcCtD
Timolol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000237	0.000613	CcSEcCtD
Timolol—Fatigue—Docetaxel—pancreatic cancer	0.000236	0.000612	CcSEcCtD
Timolol—Angiopathy—Epirubicin—pancreatic cancer	0.000236	0.000612	CcSEcCtD
Timolol—Nausea—Irinotecan—pancreatic cancer	0.000236	0.00061	CcSEcCtD
Timolol—Immune system disorder—Epirubicin—pancreatic cancer	0.000235	0.000609	CcSEcCtD
Timolol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000235	0.000608	CcSEcCtD
Timolol—Pain—Docetaxel—pancreatic cancer	0.000234	0.000607	CcSEcCtD
Timolol—Arrhythmia—Epirubicin—pancreatic cancer	0.000233	0.000602	CcSEcCtD
Timolol—Visual impairment—Doxorubicin—pancreatic cancer	0.000232	0.000601	CcSEcCtD
Timolol—Alopecia—Epirubicin—pancreatic cancer	0.00023	0.000596	CcSEcCtD
Timolol—Nausea—Gemcitabine—pancreatic cancer	0.000229	0.000594	CcSEcCtD
Timolol—Mental disorder—Epirubicin—pancreatic cancer	0.000228	0.000591	CcSEcCtD
Timolol—Erythema—Epirubicin—pancreatic cancer	0.000227	0.000587	CcSEcCtD
Timolol—Malnutrition—Epirubicin—pancreatic cancer	0.000227	0.000587	CcSEcCtD
Timolol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000226	0.000585	CcSEcCtD
Timolol—Nausea—Fluorouracil—pancreatic cancer	0.000226	0.000584	CcSEcCtD
Timolol—Eye disorder—Doxorubicin—pancreatic cancer	0.000225	0.000583	CcSEcCtD
Timolol—Tinnitus—Doxorubicin—pancreatic cancer	0.000225	0.000582	CcSEcCtD
Timolol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000224	0.000581	CcSEcCtD
Timolol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000224	0.000579	CcSEcCtD
Timolol—Tension—Epirubicin—pancreatic cancer	0.000222	0.000576	CcSEcCtD
Timolol—Dysgeusia—Epirubicin—pancreatic cancer	0.000222	0.000575	CcSEcCtD
Timolol—Nervousness—Epirubicin—pancreatic cancer	0.00022	0.00057	CcSEcCtD
Timolol—Angiopathy—Doxorubicin—pancreatic cancer	0.000219	0.000566	CcSEcCtD
Timolol—Immune system disorder—Doxorubicin—pancreatic cancer	0.000218	0.000563	CcSEcCtD
Timolol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000217	0.000562	CcSEcCtD
Timolol—Abdominal pain—Docetaxel—pancreatic cancer	0.000217	0.000561	CcSEcCtD
Timolol—Body temperature increased—Docetaxel—pancreatic cancer	0.000217	0.000561	CcSEcCtD
Timolol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000215	0.000557	CcSEcCtD
Timolol—Vision blurred—Epirubicin—pancreatic cancer	0.000214	0.000553	CcSEcCtD
Timolol—Alopecia—Doxorubicin—pancreatic cancer	0.000213	0.000551	CcSEcCtD
Timolol—Mental disorder—Doxorubicin—pancreatic cancer	0.000211	0.000547	CcSEcCtD
Timolol—Erythema—Doxorubicin—pancreatic cancer	0.00021	0.000543	CcSEcCtD
Timolol—Malnutrition—Doxorubicin—pancreatic cancer	0.00021	0.000543	CcSEcCtD
Timolol—Tension—Doxorubicin—pancreatic cancer	0.000206	0.000533	CcSEcCtD
Timolol—Dysgeusia—Doxorubicin—pancreatic cancer	0.000205	0.000532	CcSEcCtD
Timolol—Nervousness—Doxorubicin—pancreatic cancer	0.000204	0.000527	CcSEcCtD
Timolol—Vertigo—Epirubicin—pancreatic cancer	0.000204	0.000527	CcSEcCtD
Timolol—Syncope—Epirubicin—pancreatic cancer	0.000203	0.000526	CcSEcCtD
Timolol—Hypersensitivity—Docetaxel—pancreatic cancer	0.000202	0.000523	CcSEcCtD
Timolol—Palpitations—Epirubicin—pancreatic cancer	0.0002	0.000519	CcSEcCtD
Timolol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000199	0.000516	CcSEcCtD
Timolol—Cough—Epirubicin—pancreatic cancer	0.000198	0.000512	CcSEcCtD
Timolol—Vision blurred—Doxorubicin—pancreatic cancer	0.000198	0.000512	CcSEcCtD
Timolol—Asthenia—Docetaxel—pancreatic cancer	0.000197	0.00051	CcSEcCtD
Timolol—Hypertension—Epirubicin—pancreatic cancer	0.000196	0.000507	CcSEcCtD
Timolol—Pruritus—Docetaxel—pancreatic cancer	0.000194	0.000502	CcSEcCtD
Timolol—Myalgia—Epirubicin—pancreatic cancer	0.000193	0.0005	CcSEcCtD
Timolol—Arthralgia—Epirubicin—pancreatic cancer	0.000193	0.0005	CcSEcCtD
Timolol—Chest pain—Epirubicin—pancreatic cancer	0.000193	0.0005	CcSEcCtD
Timolol—Anxiety—Epirubicin—pancreatic cancer	0.000192	0.000498	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000192	0.000496	CcSEcCtD
Timolol—Discomfort—Epirubicin—pancreatic cancer	0.000191	0.000494	CcSEcCtD
Timolol—Dry mouth—Epirubicin—pancreatic cancer	0.000189	0.000489	CcSEcCtD
Timolol—Vertigo—Doxorubicin—pancreatic cancer	0.000188	0.000488	CcSEcCtD
Timolol—Syncope—Doxorubicin—pancreatic cancer	0.000188	0.000487	CcSEcCtD
Timolol—Diarrhoea—Docetaxel—pancreatic cancer	0.000188	0.000486	CcSEcCtD
Timolol—Confusional state—Epirubicin—pancreatic cancer	0.000186	0.000483	CcSEcCtD
Timolol—Palpitations—Doxorubicin—pancreatic cancer	0.000185	0.00048	CcSEcCtD
Timolol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000185	0.000479	CcSEcCtD
Timolol—Oedema—Epirubicin—pancreatic cancer	0.000185	0.000479	CcSEcCtD
Timolol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000184	0.000477	CcSEcCtD
Timolol—Infection—Epirubicin—pancreatic cancer	0.000184	0.000476	CcSEcCtD
Timolol—Cough—Doxorubicin—pancreatic cancer	0.000183	0.000474	CcSEcCtD
Timolol—Shock—Epirubicin—pancreatic cancer	0.000182	0.000471	CcSEcCtD
Timolol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000181	0.00047	CcSEcCtD
Timolol—Dizziness—Docetaxel—pancreatic cancer	0.000181	0.00047	CcSEcCtD
Timolol—Hypertension—Doxorubicin—pancreatic cancer	0.000181	0.000469	CcSEcCtD
Timolol—Skin disorder—Epirubicin—pancreatic cancer	0.00018	0.000465	CcSEcCtD
Timolol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000179	0.000463	CcSEcCtD
Timolol—Myalgia—Doxorubicin—pancreatic cancer	0.000178	0.000462	CcSEcCtD
Timolol—Arthralgia—Doxorubicin—pancreatic cancer	0.000178	0.000462	CcSEcCtD
Timolol—Chest pain—Doxorubicin—pancreatic cancer	0.000178	0.000462	CcSEcCtD
Timolol—Anxiety—Doxorubicin—pancreatic cancer	0.000178	0.000461	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000177	0.000459	CcSEcCtD
Timolol—Discomfort—Doxorubicin—pancreatic cancer	0.000176	0.000457	CcSEcCtD
Timolol—Anorexia—Epirubicin—pancreatic cancer	0.000176	0.000457	CcSEcCtD
Timolol—Dry mouth—Doxorubicin—pancreatic cancer	0.000175	0.000452	CcSEcCtD
Timolol—Vomiting—Docetaxel—pancreatic cancer	0.000174	0.000452	CcSEcCtD
Timolol—Rash—Docetaxel—pancreatic cancer	0.000173	0.000448	CcSEcCtD
Timolol—Hypotension—Epirubicin—pancreatic cancer	0.000173	0.000448	CcSEcCtD
Timolol—Dermatitis—Docetaxel—pancreatic cancer	0.000173	0.000447	CcSEcCtD
Timolol—Confusional state—Doxorubicin—pancreatic cancer	0.000173	0.000447	CcSEcCtD
Timolol—Headache—Docetaxel—pancreatic cancer	0.000172	0.000445	CcSEcCtD
Timolol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000171	0.000443	CcSEcCtD
Timolol—Oedema—Doxorubicin—pancreatic cancer	0.000171	0.000443	CcSEcCtD
Timolol—Infection—Doxorubicin—pancreatic cancer	0.00017	0.00044	CcSEcCtD
Timolol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000168	0.000436	CcSEcCtD
Timolol—Shock—Doxorubicin—pancreatic cancer	0.000168	0.000436	CcSEcCtD
Timolol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000168	0.000435	CcSEcCtD
Timolol—Insomnia—Epirubicin—pancreatic cancer	0.000167	0.000433	CcSEcCtD
Timolol—Skin disorder—Doxorubicin—pancreatic cancer	0.000166	0.000431	CcSEcCtD
Timolol—Paraesthesia—Epirubicin—pancreatic cancer	0.000166	0.00043	CcSEcCtD
Timolol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000165	0.000428	CcSEcCtD
Timolol—Dyspnoea—Epirubicin—pancreatic cancer	0.000165	0.000427	CcSEcCtD
Timolol—Somnolence—Epirubicin—pancreatic cancer	0.000164	0.000426	CcSEcCtD
Timolol—Anorexia—Doxorubicin—pancreatic cancer	0.000163	0.000422	CcSEcCtD
Timolol—Nausea—Docetaxel—pancreatic cancer	0.000163	0.000422	CcSEcCtD
Timolol—Dyspepsia—Epirubicin—pancreatic cancer	0.000163	0.000422	CcSEcCtD
Timolol—Decreased appetite—Epirubicin—pancreatic cancer	0.000161	0.000416	CcSEcCtD
Timolol—Hypotension—Doxorubicin—pancreatic cancer	0.00016	0.000414	CcSEcCtD
Timolol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00016	0.000414	CcSEcCtD
Timolol—Fatigue—Epirubicin—pancreatic cancer	0.000159	0.000413	CcSEcCtD
Timolol—Pain—Epirubicin—pancreatic cancer	0.000158	0.00041	CcSEcCtD
Timolol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000156	0.000404	CcSEcCtD
Timolol—Insomnia—Doxorubicin—pancreatic cancer	0.000155	0.000401	CcSEcCtD
Timolol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000154	0.000398	CcSEcCtD
Timolol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000153	0.000395	CcSEcCtD
Timolol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000152	0.000395	CcSEcCtD
Timolol—Somnolence—Doxorubicin—pancreatic cancer	0.000152	0.000394	CcSEcCtD
Timolol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000151	0.000392	CcSEcCtD
Timolol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000151	0.00039	CcSEcCtD
Timolol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000149	0.000385	CcSEcCtD
Timolol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000148	0.000383	CcSEcCtD
Timolol—Fatigue—Doxorubicin—pancreatic cancer	0.000148	0.000382	CcSEcCtD
Timolol—Urticaria—Epirubicin—pancreatic cancer	0.000147	0.000381	CcSEcCtD
Timolol—Pain—Doxorubicin—pancreatic cancer	0.000146	0.000379	CcSEcCtD
Timolol—Body temperature increased—Epirubicin—pancreatic cancer	0.000146	0.000379	CcSEcCtD
Timolol—Abdominal pain—Epirubicin—pancreatic cancer	0.000146	0.000379	CcSEcCtD
Timolol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000141	0.000365	CcSEcCtD
Timolol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00014	0.000362	CcSEcCtD
Timolol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000136	0.000353	CcSEcCtD
Timolol—Urticaria—Doxorubicin—pancreatic cancer	0.000136	0.000352	CcSEcCtD
Timolol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000135	0.00035	CcSEcCtD
Timolol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000135	0.00035	CcSEcCtD
Timolol—Asthenia—Epirubicin—pancreatic cancer	0.000133	0.000344	CcSEcCtD
Timolol—Pruritus—Epirubicin—pancreatic cancer	0.000131	0.000339	CcSEcCtD
Timolol—Diarrhoea—Epirubicin—pancreatic cancer	0.000127	0.000328	CcSEcCtD
Timolol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000126	0.000327	CcSEcCtD
Timolol—Asthenia—Doxorubicin—pancreatic cancer	0.000123	0.000318	CcSEcCtD
Timolol—Dizziness—Epirubicin—pancreatic cancer	0.000122	0.000317	CcSEcCtD
Timolol—Pruritus—Doxorubicin—pancreatic cancer	0.000121	0.000314	CcSEcCtD
Timolol—Vomiting—Epirubicin—pancreatic cancer	0.000118	0.000305	CcSEcCtD
Timolol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000117	0.000303	CcSEcCtD
Timolol—Rash—Epirubicin—pancreatic cancer	0.000117	0.000302	CcSEcCtD
Timolol—Dermatitis—Epirubicin—pancreatic cancer	0.000116	0.000302	CcSEcCtD
Timolol—Headache—Epirubicin—pancreatic cancer	0.000116	0.0003	CcSEcCtD
Timolol—Dizziness—Doxorubicin—pancreatic cancer	0.000113	0.000293	CcSEcCtD
Timolol—Nausea—Epirubicin—pancreatic cancer	0.00011	0.000285	CcSEcCtD
Timolol—Vomiting—Doxorubicin—pancreatic cancer	0.000109	0.000282	CcSEcCtD
Timolol—Rash—Doxorubicin—pancreatic cancer	0.000108	0.000279	CcSEcCtD
Timolol—Dermatitis—Doxorubicin—pancreatic cancer	0.000108	0.000279	CcSEcCtD
Timolol—Headache—Doxorubicin—pancreatic cancer	0.000107	0.000278	CcSEcCtD
Timolol—Nausea—Doxorubicin—pancreatic cancer	0.000102	0.000263	CcSEcCtD
Timolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	4.69e-05	0.000634	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	4.69e-05	0.000634	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	4.69e-05	0.000633	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.65e-05	0.000628	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	4.62e-05	0.000624	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	4.59e-05	0.00062	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	4.59e-05	0.00062	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	4.59e-05	0.00062	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4.55e-05	0.000614	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	4.51e-05	0.00061	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SMAD4—pancreatic cancer	4.51e-05	0.000609	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	4.5e-05	0.000608	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	4.48e-05	0.000605	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CXCL8—pancreatic cancer	4.46e-05	0.000603	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.43e-05	0.000598	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	4.41e-05	0.000596	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HES1—pancreatic cancer	4.4e-05	0.000595	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.38e-05	0.000592	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	4.38e-05	0.000591	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	4.31e-05	0.000583	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.27e-05	0.000577	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ARG2—pancreatic cancer	4.24e-05	0.000573	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CB—pancreatic cancer	4.22e-05	0.00057	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	4.21e-05	0.000568	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	4.18e-05	0.000565	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	4.16e-05	0.000561	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ARG2—pancreatic cancer	4.14e-05	0.000559	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	4.12e-05	0.000556	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	4.09e-05	0.000553	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	4.06e-05	0.000549	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CXCL8—pancreatic cancer	4.05e-05	0.000548	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	3.99e-05	0.000539	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	3.99e-05	0.000539	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.96e-05	0.000535	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	3.9e-05	0.000527	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	3.9e-05	0.000527	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.9e-05	0.000527	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TERT—pancreatic cancer	3.86e-05	0.000521	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.86e-05	0.000521	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMP—pancreatic cancer	3.71e-05	0.000501	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HIF1A—pancreatic cancer	3.69e-05	0.000499	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TSC2—pancreatic cancer	3.68e-05	0.000497	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	3.65e-05	0.000493	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMP—pancreatic cancer	3.62e-05	0.000489	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—APOE—pancreatic cancer	3.6e-05	0.000487	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.6e-05	0.000486	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	3.57e-05	0.000482	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	3.57e-05	0.000482	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	3.56e-05	0.00048	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.55e-05	0.00048	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.54e-05	0.000479	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KDR—pancreatic cancer	3.53e-05	0.000477	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.52e-05	0.000476	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	3.49e-05	0.000472	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	3.48e-05	0.00047	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.47e-05	0.000469	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMP—pancreatic cancer	3.41e-05	0.000461	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	3.37e-05	0.000455	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NFKBIA—pancreatic cancer	3.36e-05	0.000454	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOTCH1—pancreatic cancer	3.33e-05	0.000449	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.31e-05	0.000447	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	3.29e-05	0.000445	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.28e-05	0.000443	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.27e-05	0.000441	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CG—pancreatic cancer	3.25e-05	0.000439	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—NRAS—pancreatic cancer	3.25e-05	0.000439	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	3.25e-05	0.000439	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGF—pancreatic cancer	3.21e-05	0.000434	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	3.2e-05	0.000432	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	3.18e-05	0.00043	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.16e-05	0.000427	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	3.1e-05	0.000419	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.09e-05	0.000418	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.06e-05	0.000413	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	3.06e-05	0.000413	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	3.03e-05	0.00041	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.01e-05	0.000407	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	2.99e-05	0.000404	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GLP1R—pancreatic cancer	2.99e-05	0.000404	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EGFR—pancreatic cancer	2.96e-05	0.0004	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—DPYD—pancreatic cancer	2.94e-05	0.000397	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.92e-05	0.000394	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.92e-05	0.000394	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.87e-05	0.000388	CbGpPWpGaD
Timolol—ABCB1—Metabolism—DPYD—pancreatic cancer	2.87e-05	0.000388	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CD—pancreatic cancer	2.86e-05	0.000386	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.83e-05	0.000383	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.81e-05	0.00038	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—KRAS—pancreatic cancer	2.8e-05	0.000378	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	2.79e-05	0.000377	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.76e-05	0.000373	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.76e-05	0.000372	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.75e-05	0.000371	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.72e-05	0.000368	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.7e-05	0.000365	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.7e-05	0.000364	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	2.68e-05	0.000362	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.66e-05	0.00036	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.65e-05	0.000358	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	2.62e-05	0.000354	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	2.61e-05	0.000353	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.59e-05	0.00035	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CA—pancreatic cancer	2.57e-05	0.000347	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.57e-05	0.000347	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	2.56e-05	0.000346	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.5e-05	0.000338	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CB—pancreatic cancer	2.49e-05	0.000337	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.46e-05	0.000333	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.45e-05	0.000331	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.43e-05	0.000328	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	2.41e-05	0.000325	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—pancreatic cancer	2.39e-05	0.000324	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HRAS—pancreatic cancer	2.38e-05	0.000321	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	2.35e-05	0.000318	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—pancreatic cancer	2.31e-05	0.000313	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—pancreatic cancer	2.29e-05	0.00031	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	2.29e-05	0.00031	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	2.24e-05	0.000303	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—pancreatic cancer	2.23e-05	0.000301	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CTNNB1—pancreatic cancer	2.21e-05	0.000298	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	2.19e-05	0.000296	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	2.19e-05	0.000295	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—pancreatic cancer	2.17e-05	0.000293	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CD44—pancreatic cancer	2.16e-05	0.000292	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—pancreatic cancer	2.15e-05	0.000291	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	2.14e-05	0.00029	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	2.14e-05	0.000289	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	2.14e-05	0.000289	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.12e-05	0.000286	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CD44—pancreatic cancer	2.11e-05	0.000285	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—pancreatic cancer	2.1e-05	0.000284	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.1e-05	0.000283	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	2.1e-05	0.000283	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	2.09e-05	0.000283	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GCG—pancreatic cancer	2.07e-05	0.00028	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	2.05e-05	0.000277	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GCG—pancreatic cancer	2.02e-05	0.000273	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—pancreatic cancer	2e-05	0.00027	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	1.99e-05	0.000269	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CD44—pancreatic cancer	1.99e-05	0.000268	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	1.97e-05	0.000267	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	1.95e-05	0.000263	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—STK11—pancreatic cancer	1.95e-05	0.000263	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—pancreatic cancer	1.94e-05	0.000263	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	1.93e-05	0.000261	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	1.93e-05	0.000261	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	1.93e-05	0.000261	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—pancreatic cancer	1.93e-05	0.00026	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NRAS—pancreatic cancer	1.92e-05	0.00026	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	1.91e-05	0.000258	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GCG—pancreatic cancer	1.91e-05	0.000257	CbGpPWpGaD
Timolol—ABCB1—Metabolism—STK11—pancreatic cancer	1.9e-05	0.000257	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	1.89e-05	0.000255	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	1.89e-05	0.000255	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	1.87e-05	0.000252	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.83e-05	0.000247	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—STK11—pancreatic cancer	1.79e-05	0.000242	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—pancreatic cancer	1.79e-05	0.000242	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—pancreatic cancer	1.79e-05	0.000241	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	1.76e-05	0.000238	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—pancreatic cancer	1.75e-05	0.000236	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	1.72e-05	0.000232	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	1.7e-05	0.000229	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.68e-05	0.000227	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.68e-05	0.000226	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	1.66e-05	0.000224	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	1.66e-05	0.000224	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—pancreatic cancer	1.65e-05	0.000223	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.64e-05	0.000222	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMS—pancreatic cancer	1.63e-05	0.000221	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	1.63e-05	0.00022	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.54e-05	0.000208	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.53e-05	0.000206	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—pancreatic cancer	1.52e-05	0.000205	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.49e-05	0.000202	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	1.48e-05	0.0002	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—pancreatic cancer	1.47e-05	0.000199	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	1.45e-05	0.000195	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	1.42e-05	0.000192	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	1.41e-05	0.000191	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HRAS—pancreatic cancer	1.41e-05	0.00019	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	1.39e-05	0.000188	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	1.38e-05	0.000187	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	1.37e-05	0.000185	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APOE—pancreatic cancer	1.36e-05	0.000184	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	1.36e-05	0.000184	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	1.34e-05	0.000181	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	1.33e-05	0.00018	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APOE—pancreatic cancer	1.33e-05	0.00018	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	1.32e-05	0.000179	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	1.31e-05	0.000177	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	1.3e-05	0.000175	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.29e-05	0.000174	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	1.29e-05	0.000174	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	1.28e-05	0.000173	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	1.28e-05	0.000173	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	1.26e-05	0.00017	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APOE—pancreatic cancer	1.25e-05	0.000169	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	1.25e-05	0.000169	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	1.25e-05	0.000168	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—pancreatic cancer	1.24e-05	0.000168	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.23e-05	0.000166	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	1.22e-05	0.000165	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.2e-05	0.000162	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.19e-05	0.00016	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	1.19e-05	0.00016	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	1.16e-05	0.000157	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—pancreatic cancer	1.16e-05	0.000156	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	1.15e-05	0.000156	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	1.14e-05	0.000154	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	1.14e-05	0.000154	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.13e-05	0.000153	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	1.13e-05	0.000153	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	1.12e-05	0.000151	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	1.12e-05	0.000151	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.09e-05	0.000147	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.08e-05	0.000146	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	1.06e-05	0.000143	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	1.06e-05	0.000143	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.05e-05	0.000143	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	1.04e-05	0.00014	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	1.04e-05	0.00014	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	1.04e-05	0.00014	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	1.02e-05	0.000137	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	9.94e-06	0.000134	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	9.81e-06	0.000133	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	9.6e-06	0.00013	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	9.42e-06	0.000127	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—pancreatic cancer	9.33e-06	0.000126	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—pancreatic cancer	9.2e-06	0.000124	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—pancreatic cancer	9.11e-06	0.000123	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	9.02e-06	0.000122	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	8.82e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	8.72e-06	0.000118	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	8.67e-06	0.000117	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	8.59e-06	0.000116	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	8.53e-06	0.000115	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	8.34e-06	0.000113	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	8.16e-06	0.00011	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—pancreatic cancer	8.14e-06	0.00011	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—pancreatic cancer	7.95e-06	0.000107	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—pancreatic cancer	7.49e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	7.37e-06	9.95e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	7.21e-06	9.73e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	5.74e-06	7.76e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—pancreatic cancer	5.61e-06	7.57e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	5.28e-06	7.14e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—pancreatic cancer	4.69e-06	6.34e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—pancreatic cancer	4.58e-06	6.19e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—pancreatic cancer	4.32e-06	5.83e-05	CbGpPWpGaD
